208 related articles for article (PubMed ID: 24611579)
1. Biomarker discovery of nasopharyngeal carcinoma by proteomics.
Xiao L; Xiao T; Wang ZM; Cho WC; Xiao ZQ
Expert Rev Proteomics; 2014 Apr; 11(2):215-25. PubMed ID: 24611579
[TBL] [Abstract][Full Text] [Related]
2. Research status and prospects of biomarkers for nasopharyngeal carcinoma in the era of high‑throughput omics (Review).
Zhang SQ; Pan SM; Liang SX; Han YS; Chen HB; Li JC
Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649830
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis to identify cytokeratin 18 as a novel biomarker of nasopharyngeal carcinoma.
Li XM; Huang WG; Yi H; Cheng AL; Xiao ZQ
J Cancer Res Clin Oncol; 2009 Dec; 135(12):1763-75. PubMed ID: 19529960
[TBL] [Abstract][Full Text] [Related]
4. Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.
Chen Z; Long L; Wang K; Cui F; Zhu L; Tao Y; Wu Q; Xiang M; Liang Y; Qiu S; Xiao Z; Yi B
Oncotarget; 2016 Jun; 7(23):34022-37. PubMed ID: 27145374
[TBL] [Abstract][Full Text] [Related]
5. Omics-based identification of biomarkers for nasopharyngeal carcinoma.
Janvilisri T
Dis Markers; 2015; 2015():762128. PubMed ID: 25999660
[TBL] [Abstract][Full Text] [Related]
6. DNA Methylation Biomarkers for Nasopharyngeal Carcinoma: Diagnostic and Prognostic Tools.
Jiang W; Cai R; Chen QQ
Asian Pac J Cancer Prev; 2015; 16(18):8059-65. PubMed ID: 26745039
[TBL] [Abstract][Full Text] [Related]
7. SWATH-based proteomics identified carbonic anhydrase 2 as a potential diagnosis biomarker for nasopharyngeal carcinoma.
Luo Y; Mok TS; Lin X; Zhang W; Cui Y; Guo J; Chen X; Zhang T; Wang T
Sci Rep; 2017 Jan; 7():41191. PubMed ID: 28117408
[TBL] [Abstract][Full Text] [Related]
8. Proteome profiling of Epstein-Barr virus infected nasopharyngeal carcinoma cell line: identification of potential biomarkers by comparative iTRAQ-coupled 2D LC/MS-MS analysis.
Feng X; Zhang J; Chen WN; Ching CB
J Proteomics; 2011 Apr; 74(4):567-76. PubMed ID: 21296196
[TBL] [Abstract][Full Text] [Related]
9. Identification of CALM as the potential serum biomarker for predicting the recurrence of nasopharyngeal carcinoma using a mass spectrometry-based comparative proteomic approach.
Meng H; Zhu X; Li L; Liang Z; Li X; Pan X; Zeng F; Qu S
Int J Mol Med; 2017 Oct; 40(4):1152-1164. PubMed ID: 28849027
[TBL] [Abstract][Full Text] [Related]
10. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
[TBL] [Abstract][Full Text] [Related]
11. Identification of candidate biomarkers for the early detection of nasopharyngeal carcinoma by quantitative proteomic analysis.
Yang J; Zhou M; Zhao R; Peng S; Luo Z; Li X; Cao L; Tang K; Ma J; Xiong W; Fan S; Schmitt DC; Tan M; Li X; Li G
J Proteomics; 2014 Sep; 109():162-75. PubMed ID: 24998431
[TBL] [Abstract][Full Text] [Related]
12. A Review: Proteomics in Nasopharyngeal Carcinoma.
Chen ZT; Liang ZG; Zhu XD
Int J Mol Sci; 2015 Jul; 16(7):15497-530. PubMed ID: 26184160
[TBL] [Abstract][Full Text] [Related]
13. Novel biomarkers of nasopharyngeal carcinoma metastasis risk identified by reverse phase protein array based tumor profiling with consideration of plasma Epstein-Barr virus DNA load.
Xu T; Su B; Huang P; Wei W; Deng Y; Sehgal V; Wang D; Jiang J; Zhang G; Li A; Yang H; Claret FX
Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 27883284
[TBL] [Abstract][Full Text] [Related]
14. E3-ligase Skp2 predicts poor prognosis and maintains cancer stem cell pool in nasopharyngeal carcinoma.
Wang J; Huang Y; Guan Z; Zhang JL; Su HK; Zhang W; Yue CF; Yan M; Guan S; Liu QQ
Oncotarget; 2014 Jul; 5(14):5591-601. PubMed ID: 25015320
[TBL] [Abstract][Full Text] [Related]
15. Proteomics Profiling Reveals the Molecular Signatures and Potential Therapeutic Targets of Human Nasopharyngeal Carcinoma.
Fu Y; Liang X; Yang X; Liu J; Huang H; Zhang P; Li S; Zhu D; Zhang Y; Peng F; Chen Y; Chen Z
Mol Cell Proteomics; 2023 Jun; 22(6):100567. PubMed ID: 37172717
[TBL] [Abstract][Full Text] [Related]
16. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis.
Cheng AL; Huang WG; Chen ZC; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Peng F; Duan CJ; Xiao ZQ
J Proteome Res; 2008 Jun; 7(6):2415-26. PubMed ID: 18433155
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs: potential diagnostic markers and therapeutic targets for EBV-associated nasopharyngeal carcinoma.
He ML; Luo MX; Lin MC; Kung HF
Biochim Biophys Acta; 2012 Jan; 1825(1):1-10. PubMed ID: 21958739
[TBL] [Abstract][Full Text] [Related]
18. Correlations of the expressions of c-Jun and Egr-1 proteins with clinicopathological features and prognosis of patients with nasopharyngeal carcinoma.
Zhong JT; Wang HJ; Yu J; Zhang JH; Wang SF; Yang X; Su W
Cancer Biomark; 2017; 19(2):213-220. PubMed ID: 28269757
[TBL] [Abstract][Full Text] [Related]
19. Correlation of five secretory proteins with the nasopharyngeal carcinoma metastasis and the clinical applications.
Tao Y; Wang K; Chen Z; Long L; Wu Q; Cui F; Zhu L; Xiang M; Jiang Y; Liang Y; Qiu S; Xiao Z; Yi B
Oncotarget; 2017 Apr; 8(17):29383-29394. PubMed ID: 28107202
[TBL] [Abstract][Full Text] [Related]
20. Low-molecular-mass secretome profiling identifies C-C motif chemokine 5 as a potential plasma biomarker and therapeutic target for nasopharyngeal carcinoma.
Lin SJ; Chang KP; Hsu CW; Chi LM; Chien KY; Liang Y; Tsai MH; Lin YT; Yu JS
J Proteomics; 2013 Dec; 94():186-201. PubMed ID: 24080422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]